UTMB and HDT Bio awarded prototype project funding worth up to $87.4M from the U.S. government to develop saRNA vaccine technology

GALVESTON, Texas & SEATTLE--(BUSINESS WIRE)--Two deadly viruses significant to the military to be targets for vaccine protection: Crimean-Congo hemorrhagic fever virus and Nipah virus.